Zhen-Gang Yuan - AI Profile | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comprehensive Genomic Profiling in Solid Tumors: Enhancing Treatment Selection and Prognosis

Minghui Wang,Yanhong Shang,Zhen-gang Yuan, Qing Hao,Zhizheng Wang,Dong You, Yang Liu,Fei Pang,Wei Rao,Yinying Wu,Leilei Lu

Journal of Clinical Oncologyno. 16_suppl (2024): e13631-e13631

引用0浏览0引用

Superior Survival Benefits of Triple Combination Immunotherapy Compared to Standard Chemotherapy As Second-Line Treatment for Advanced Biliary Tract Cancer: a Retrospective Analysis

Peipei Shang, Heming Xu,Tianmei Zeng,Cheng Lou, Wei,Guang Yang,Zhuo Cheng, Xiaowen Cui, Weipeng Hong, Weidong Shen, Zhicong Lian,Zhengang Yuan

Frontiers in oncology (2024): 1482909-1482909

引用0浏览0WOS引用

Clinical and Biomarker Analyses of Sintilimab Plus Gemcitabine and Cisplatin As First-Line Treatment for Patients with Advanced Biliary Tract Cancer

Tian-mei Zeng,Guang Yang,Cheng Lou, Wei,Chen-jie Tao,Xi-yun Chen,Qin Han,Zhuo Cheng,Pei-pei Shang,Yu-long Dong,He-ming Xu,Lie-ping Guo,Dong-sheng Chen,Yun-jie Song,Chuang Qi,Wang-long Deng,Zhen-gang Yuan

NATURE COMMUNICATIONSno. 1 (2023)

引用2浏览0WOSNATURE引用

Toripalimab Combined with Anlotinib As the Second-Line Treatment for Advanced Hepatocellular Carcinoma Patients: a Prospective, Single Arm Phase II Clinical Study

Wei,Xiyun Chen,Tianmei Zeng,Guang Yang,Yulong Dong,Chenjie Tao, Qin Han,Cheng Lou,Peipei Shang,Zhuo Cheng,Weipeng Hong,Yuange He, Weidong Shen,Zhengang Yuan,Lieping Guo

crossref（2023）

引用0浏览0引用

Toripalimab combined with anlotinib as the second-line treatment for advanced hepatocellular carcinoma patients: a prospective, single arm phase II clinical study

Wei Wei,Xiyun Chen,Tianmei Zeng,Guang Yang,Yulong Dong,Chenjie Tao,Qin Han,Cheng Lou,Peipei Shang,Zhuo Cheng,Weipeng Hong, Yan He, Weidong Shen,Zhen-gang Yuan,Lei Guo

Research Square (Research Square) (2023)

引用0浏览0引用

Advanced Renal Pelvis Carcinoma Patient with an ERBB2 Insertion Mutation: a Case Report

Peipei Shang,Cheng Lou,Lei Yin,Chenjie Tao,Yulong Dong,Guang Yang,Zhengang Yuan

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH（2023）

引用0浏览0WOS引用

Sintilimab Plus Gemcitabine and Cisplatin As a First-Line Treatment for Patients with Advanced Biliary Tract Cancer: A Biomolecular Exploratory, Phase II Clinical Trial

Zhen-Gang Yuan,Tian-Mei Zeng,Guang Yang,Cheng Lou, Wei,Chen-Jie Tao,Xi-Yun Chen,Qin Han,Zhuo Cheng,Pei-Pei Shang,Yu-Long Dong,He-Ming Xu,Lie-Ping Guo,Dong-Sheng Chen,Yunjie Song,Chuang Qi,Wanglong Deng

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Impact of Antithrombotic Drugs on the Accuracy of Fecal Occult Blood Testing for Advanced Colorectal Neoplasia Screening: a Meta-Analysis and Systematic Review

Shujie Pang,Zhipeng Lin,Zhe Sun,Yu Zhang,Zhen-gang Yuan,Ning Yang

Zeitschrift für Gastroenterologie（2022）

引用0浏览0引用

Biomarker Analysis of First-Line Sintilimab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancers: Results from a Phase II Study

Zhen-Gang Yuan,Tian-Mei Zeng,Chen-Jie Tao,Guang Yang,He-Ming Xu, Wei,Xi-Yun Chen,Zhuo Cheng,Yu-Long Dong,Pei-Pei Shang,Cheng Lou,Qin Han,Dong-Sheng Chen,Yunjie Song

Journal of clinical oncology（2022）

引用0浏览0引用

术后辅助化疗对可切除胆道恶性肿瘤的疗效分析

陶晨洁,陈熙昀,娄成,魏炜,杨光,董雨龙,曾添美,尚佩沛,袁振刚

Chinese Journal of Hepatic Surgery（Electronic Edition）no. 4 (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn